Option Care Health, Inc. (NASDAQ:OPCH) Given Average Rating of “Moderate Buy” by Brokerages

Option Care Health, Inc. (NASDAQ:OPCH) has been assigned an average recommendation of “Moderate Buy” from the eight brokerages that are presently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $32.25.

Several brokerages recently issued reports on OPCH. JMP Securities reaffirmed a “market outperform” rating and set a $30.00 price target (down from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Truist Financial lowered their price target on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a report on Friday, November 1st. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and raised their price objective for the company from $26.00 to $33.00 in a report on Monday, January 13th. The Goldman Sachs Group cut Option Care Health from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $38.00 to $27.00 in a report on Monday, November 4th. Finally, UBS Group assumed coverage on Option Care Health in a research note on Thursday, December 5th. They set a “neutral” rating and a $26.00 price target on the stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the company. Wellington Management Group LLP increased its position in shares of Option Care Health by 84.6% during the fourth quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company’s stock worth $425,143,000 after buying an additional 8,400,208 shares during the period. FMR LLC boosted its position in Option Care Health by 134.0% during the third quarter. FMR LLC now owns 7,516,448 shares of the company’s stock valued at $235,265,000 after acquiring an additional 4,304,896 shares during the last quarter. Norges Bank acquired a new stake in Option Care Health during the 4th quarter worth about $60,219,000. Victory Capital Management Inc. raised its position in shares of Option Care Health by 4,432.8% in the 3rd quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock worth $50,756,000 after acquiring an additional 1,585,818 shares in the last quarter. Finally, Voloridge Investment Management LLC acquired a new position in shares of Option Care Health in the 4th quarter valued at about $27,428,000. Institutional investors own 98.05% of the company’s stock.

Option Care Health Stock Performance

Option Care Health stock opened at $32.09 on Wednesday. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The stock has a market cap of $5.46 billion, a PE ratio of 26.97, a P/E/G ratio of 2.19 and a beta of 1.35. Option Care Health has a 12-month low of $21.39 and a 12-month high of $34.63. The business’s 50-day moving average price is $27.19 and its two-hundred day moving average price is $27.91.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.